Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment

被引：0
|
作者：
van Hooren, Luuk
Georganaki, Maria
Huang, Hua
Mangsbo, Sara
Dimberg, Anna
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1485
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1485
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8+ cytotoxic T-cell activation and antitumor immunity
    Yongqing Liu
    Xuishu Zhang
    Weidong Zhang
    Zhuang Chen
    Tim Chan
    Kaiser Ali
    Zongchao Jia
    Jim Xiang
    Cancer Gene Therapy, 2002, 9 : 202 - 208
  • [32] IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody
    Li, Ji
    Ybarra, Ryan
    Mak, Judy
    Herault, Aurelie
    De Almeida, Patricia
    Arrazate, Alfonso
    Ziai, James
    Totpal, Klara
    Junttila, Melissa R.
    Walsh, Kevin B.
    Junttila, Teemu T.
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6447 - 6458
  • [33] DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
    Muik, Alexander
    Adams, Homer C., III
    Gieseke, Friederike
    Altintas, Isil
    Schoedel, Kristina B.
    Blum, Jordan M.
    Sanger, Bianca
    Burm, Saskia M.
    Stanganello, Eliana
    Verzijl, Dennis
    Spires, Vanessa M.
    Vascotto, Fulvia
    Toker, Aras
    Quinkhardt, Juliane
    Fereshteh, Mark
    Diken, Mustafa
    Satijn, David P. E.
    Kreiter, Sebastian
    Ahmadi, Tahamtan
    Breij, Esther C. W.
    Tureci, Ozlem
    Sasser, Kate
    Sahin, Ugur
    Jure-Kunkel, Maria
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [34] T-cell activation induced by anti-CD3 × anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand
    James E. Wooldridge
    Chris E. Dahle
    George J. Weiner
    Cancer Immunology, Immunotherapy, 1997, 45 : 174 - 179
  • [35] Immunomodulation of alloreactive T-cell responses by inhibition of the CD40-mediated activation of antigen-presenting cells through blockade of protein isoprenylation
    Shimabukuro-Vornhagen, A.
    Zoghi, S.
    Theurich, S.
    Holtick, U.
    Scheid, C.
    von Bergwelt-Baildon, M. S.
    ONKOLOGIE, 2011, 34 : 214 - 214
  • [36] Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival
    Rastellini, C
    Salam, A
    Kuddus, R
    Aitouche, A
    Subbotin, V
    Braun, M
    Leach, R
    Peach, R
    Fung, JJ
    Starzl, TE
    Rao, AS
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1242 - 1243
  • [37] T-cell activation induced by anti-CD3 x anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand
    Wooldridge, JE
    Dahle, CE
    Weiner, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 45 (3-4) : 174 - 179
  • [38] Combination CD40 agonist and PD-1 antagonist antibody therapy enhances vaccine induced T cell responses in non-immunogenic cancers
    Ma, Hayley S.
    Torres, Evanthia Roussos
    Poudel, Bibhav
    Robinson, Tara
    Christmas, Brian
    Cruz, Kayla
    Woolman, Skylar
    Rafie, Christine
    Scott, Blake
    Wall, Valerie
    Armstrong, Todd
    Jaffee, Elizabeth
    CANCER RESEARCH, 2018, 78 (13)
  • [39] CROSS-LINKING OF CD4 BY HIV GP120/ANTI-GP129 ANTIBODY INSOLUBLE COMPLEXES ENHANCES T-CELL ACTIVATION
    DELLANNA, L
    CARBONARI, M
    AIUTI, F
    FIORILLI, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 722 - 722
  • [40] CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4+ T cell responses following DNA vaccination of outbred animals
    Njongmeta, Leo M.
    Bray, Jocelyn
    Davies, Christopher J.
    Davis, William C.
    Howard, Chris J.
    Hope, Jayne C.
    Palmer, Guy H.
    Brown, Wendy C.
    Mwangi, Waithaka
    VACCINE, 2012, 30 (09) : 1624 - 1635
12345